Spots Global Cancer Trial Database for ATI-2231 in Advanced Solid Tumor Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ATI-2231 in Advanced Solid Tumor Malignancies
Official Title: A Phase Ia Trial of ATI-2231 in Advanced Solid Tumor Malignancies
Study ID: NCT05791474
Interventions
Study Description
Brief Summary: The purpose of this first-in-human study is to test ATI-2231 in advanced solid tumor malignancies with the goal of establishing the recommended Phase II dose of ATI-2231.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Cynthia X Ma, M.D., Ph.D.
Affiliation: Washington University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
